Análise dosimétrica de acompanhantes de pacientes de medicina nuclear internados em quarto terapêutico

OBJECTIVE: The present study evaluated the doses received by companions who had shared therapeutic rooms with patients undergoing treatment with 131-iodine (131I). The results were compared with the limits established by the Brazilian radiation protection regulatory standard. MATERIALS AND METHODS: Six pairs of persons (a patient and a companion sharing a same therapeutic room) were evaluated. Still, other 23 experiments were accomplished with a phantom replacing the companion. The therapeutic 131I activities given to the patients corresponded to 3700 MBq or 5550 MBq. Powdered lithium fluoride thermoluminescent dosimeters doped with magnesium, titanium and sodium were utilized for evaluating the doses. RESULTS: The results demonstrate that a person sharing a same therapeutic room, for two days, with a patient who had been given 3700 MBq or 5550 MBq of 131I, according to radioprotection recommendations, is exposed to a mean dose of (0.51 ± 0.02) mSv for a 99% confidence level. CONCLUSION: According to the Brazilian radiation protection standards there is no impediment for a person to accompany a nuclear medicine patient who has been given 3700 MBq or 5550 MBq of 131I during the patient stay in the therapeutic room.